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events were compared between two groups, and independent predictors of prognosis
were also identiﬁed.
Results: Compared with patients in control group, those in IAS group had higher
ratio of hypertension (P<0.05). During follow-up (mean 5212 months), 42 cases
of end point events were recorded, including 20 major adverse cardiac events
(MACE). The rate of MACE (IAS group vs control group, 18.4% vs 3.6%,
RR¼6.03, 95% CI 1.94-18.77, P¼0.001) and end point events (33.3% vs 11.7%,
RR¼3.79, 95% CI 1.82-7.82, P<0.001) were signiﬁcantly higher in IAS group.
Multivariate Cox regression analysis revealed that CPP>45 mmHg (RR¼3.86,
95% CI 1.89-7.87, P<0.001), common carotid atherosclerotic plaque (RR¼2.17,
95% CI 1.38-3.41, P¼0.001), multivessel CAD (RR¼1.70, 95% CI1.24-2.34,
P¼0.001) and a prior history of cerebral vascular disease (RR¼3.26, 95% CI1.41-
7.52, P¼0.006) were independent predictors of prognosis of cardiovascular
diseases.
Conclusions: CPP >45mmHg and common carotid atherosclerotic plaque were in-
dependent predictors of adverse cardiac events. The results indicated a high value of
noninvasive arterial stiffness index estimation for prognosis.
GW25-e3238
Effect of the combined increase of C-reactive protein and uric acid level on
metabolic syndrome and its components
Zhu Wenhua, Fang Lizheng, Chen Jianhua, Chen Yan, Chen Liying
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Objectives: The combined effect of C-reactive protein (hs-CRP) and uric acid on
progression of metabolic syndrome (MS) is inadequately deﬁned. The aim of this
study is to evaluate the effect of the combined increase of high-sensitivity
C-reactive protein (hs-CRP) and uric acid (UA) on metabolic syndrome and its
components.
Methods: A total of 21936 subjects who took well-man or -woman check up in our
hospital were enrolled. Hs-CRP, uric acid, fasting plasma glucose, lipid proﬁle, waist
circumference and blood pressure were measured to analyze the relationship between
metabolic syndrome and its components with hs-CRP and uric acid in three groups
(low-risk group: hs-CRP<1 md/dL, mid-risk group: hs-CRP 1w3 md/dL, high-risk
group: hs-CRP>3 md/dL).
Results: (1) As hs-CRP values increased, waist circumference, uric acid, tri-
glycerides, fasting plasma glucose, systolic blood pressure, diastolic blood pressure
and high-density lipoprotein increased among the three groups. F values were 86.38,
41.11, 23.37, 18.56, 19.22, 17.88 and 12.23 separately (P<0.01). (2) Mid and high-
risk groups of hs-CRP with hyperuricemia were closely related to waist circumfer-
ence, triglycerides and systolic blood pressure. OR values were 3.26, 3.27, 1.59 and
3.77, 3.38, 1.64 separately (P<0.05). (3) The incidence of metabolic syndrome
increased gradually with the combined increases of hs-CRP and uric acid, they were
49.06% and 55.59% in the mid and high-risk groups of hs-CRP with hyperuricemia
(P<0.01).
Conclusions: With increased values of both hs-CRP and uric acid, metabolic dis-
orders tended to be worse and the incidence of metabolic syndrome was increased.
Hs-CRP and uric acid can be used as a clinical predicting or monitoring item
for MS.
GW25-e0837
Effects of tea intake on blood pressure: a meta-analysis of 21 randomized
controlled trials
Liu Gang, Huang Xiaohong
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of
Medical Sciences & Peking Union Medical College
Objectives: The effect of tea intake on blood pressure (BP) is controversial. We
undertook a meta-analysis of randomized controlled trials to determine changes in
systolic and diastolic BP due to the intake black and green tea.
Methods: MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were
searched from 1966 until January 2014 for studies in parallel group or crossover
design in which BP was assessed before and after receiving black or green tea for at
least 1 week. The weighted mean difference was calculated for net changes in BP by
using ﬁxed-effects or random-effects models. Previously deﬁned subgroup analyses
were performed to explore the inﬂuence of study characteristics.
Results: 21 eligible randomized controlled trials with 1323 subjects were enrolled.
After the tea intake, the pooled mean systolic and diastolic BP were 1.8 mmHg
(95% conﬁdence interval [CI], 2.4- 1.1 mmHg) and 1.4mmHg (95% CI, 2.2-
0.6 mm Hg) lower, respectively, compared with the tea-free controls. Subgroup
analyses showed that the BP-lowering effect was apparent in the subjects who
consumed a tea over a median of 12 weeks (systolic/diastolic BP, -2.6/-2.1 mmHg,
both P <0.001). Stratiﬁed by type of tea, green tea signiﬁcantly reduced systolic and
diastolic BP of -2.1 (95% CI, 2.9- 1.2) and -1.7 (95% CI, 2.9- 0.5) mm Hg,
and black tea signiﬁcantly reduced systolic and diastolic BP of -1.4 (95% CI, 2.4-
0.4) and -1.1 (95% CI, -1.9- 0.2) mm Hg, respectively. The beneﬁts of tea intake
were not inﬂuenced by ethnicity, treatment dose of tea catechins, individual health
status, or caffeine intake.
Conclusions: The meta-analysis showed that long-term (12 weeks) ingestion
of a tea (green and black tea) resulted in a signiﬁcant reduction in systolic and
diastolic BP.C112 JACC Vol 64/16/Suppl C j October 16Diabetes
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Objectives: Musclin is a skeletal muscle-derived secretory factor discovered in
2004. A limited number of studies have addressed the relationship between
musclin levels and the alterations of endogenous musclin in type 2 diabetes mel-
litus (T2DM). To ﬁll this blank, this study examined the changes of musclin levels
in plasma and therefore indicated the association between musclin levels and
T2DM.
Methods: In this hospital-based case-control study, 38 newly diagnosed T2DM
subjects who never received anti-diabetic therapy, 41 T2DM subjects under insulin
treatment were enrolled from outpatient department of the Second Afﬁliated Hos-
pital of Harbin Medical University, and the 41 normal subjects with no medical
history were recruited from the health check-up population of our hospital. Fasting
plasma glucose (FPG), serum insulin, hemoglobin A1c (HbA1c) and blood lipid
proﬁle were determined using commercially available diagnostic reagents at the
clinical biochemical laboratories. Plasma musclin levels were measured by
radioimmunoassay.
Results: Plasma musclin levels were signiﬁcantly higher in the newly diagnosed
T2DM group compared with the normal group (83.0716.16 ng/L vs 93.1815.50
ng/L, P <0.01) and were signiﬁcantly decreased in T2DM patients with insulin
therapy (93.1815.50 ng/L vs 83.7419.12 ng/L, P<0.05). Musclin levels in
plasma of newly diagnosed T2DM patients were positively correlated with FPG
(r¼0.467, P<0.01), HbA1c (r¼0.383, P<0.05), serum insulin (r¼0.551, P<0.01),
triglycerides (r¼0.452, P<0.01) and homeostasis model assessment of insulin
resistance (HOMA-IR) (r¼0.388, P<0.05). High-density lipoprotein cholesterol
(HDL-C) levels were negatively correlated with musclin levels (r¼-0.339,
P<0.05).
Conclusions: An upregulation of plasma musclin level increase the risk of T2DM.
There might be a connection between musclin and the pathogenesis of T2DM.
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Objectives: The atherosclerosis risk in communities (ARIC) study have demonstrated
that lower heart rate variability (HRV) is associated with the development of coronary
heart disease (CAD) in individuals with diabetes. However, the relationship between
blood glucose variability and HRV remains unclear. The present study aimed to
explore the impact of glucose variability on HRV in patients with type 2 diabetes
mellitus (T2DM).
Methods: According to glucose variability, assessed by mean amplitude of gly-
cemic excursions (MAGE) obtained from continuous glucose monitoring sys-
tem(CGMS), 68 consecutive type 2 diabetic patients without CAD were divided
into two groups: subjects with non-glucose ﬂuctuation (MAGE<3.9 mmol/l,
n¼32) and subjects with glucose ﬂuctuation (MAGE>¼3.9mmol/l, n¼36). Thirty
healthy controls (NC) were also enrolled. HRV was assessed by dynamic elec-
trocardiogram examination. HRV analysis included time domain parameters such
as SDNN, SDANN, rMSSD and pNN50, and total spectral power (TP) of HRV,
which mainly consists of VLF, LF and HF component along with LF/HF ratio, was
also obtained.
Results: Compared with NC, all the time domain measures were signiﬁcantly lower
in T2DM (SDNN: 92.2.823.1 vs 121.727.4, P<0.05; SDANN: 78.722.9 vs
106.222.5, P<0.05; rMSSD: 27.510.2 vs 35.710.1, P<0.05; and pNN50:
6.07.1 vs 8.87.8, P<0.05). For frequency domain, LF and HF were signiﬁcantly
lower in T2DM (LF:300.2237.8 vs 398.7277.5, P<0.05; HF: 141.8121.5 vs
186.5171.5, P<0.05) whereas VLF and LF/HF ratio were comparable (P>0.05). In
cases with glucose ﬂuctuation, SDNN(79.122.1 vs 100.824.1, P<0.05), SDANN
(61.323.8 vs 88.720.9, P<0.05), rMSSD (23.110.5 vs 29.311.5, P<0.05),
PNN50 (4.96.6 vs 6.56.1, P<0.05), TP (1290.8902.3 vs 1727.01131.5,
P<0.05) and HF (102.1110.7 vs 139.8122.4, P<0.05) were all signiﬁcantly
lower than those in non-glucose ﬂuctuation subjects. No signiﬁcant differences in
VLF (1190.4861.6 vs 1285.6858.0, P>0.05) and LF (274.9223.0 vs–19, 2014 j GW-ICC Abstracts/Epidemiology, Prevention and Control
